Member Info for Laura2022

All over the place at the moment

Must be something going on behind the shadow

Climbing above 27p

Hope people got some CWR at70p...up at 85p now

Took some ONC too

Currently 3.3p to buy and 3.34p to sell !!

My first £1000 at3.3p

Outlook for FY2025

· Oncimmune expects FY2025 revenue to be in the region of £4m, which would be an uplift of 33% vs FY2024 and growth of around 250% vs FY2023.

· As at 31 January 2025, the Company has cash balances of over £1m and has paid down some debt such that only £1.5m of the principal loan remains outstanding as at 31 January 2025.

Hi Rooster

Yeah? I saw the 3.26p buys so thought I could get some at 3.3p , it's 3.38p to buy so I may need to take the plunge

Yeah..the Info was from this month's results

Looks tempting given the drop from 13p to here and fund raise much higher in Nov 2024

I'm also carefully watching ONC

Hello

See my summaries yesterday, hope that helps

Had orders at 3.3p cancelled

You were also right about the WRAP likely to be oversubscribed

I was cut back by 20% so bought some more this week

All buys showing as sells last 4 days

 Physiomics has achieved a record year for the total value of contract wins and is tracking in line with expectations for the full year ending 30 June 2025. The quality and impact of the Company's solutions can be evidenced in the two recent publications, with partners Astellas Pharma Inc and Merck KGaA, but also the success of Numab Therapeutics' NM26 asset - an early clinical programme supported by Physiomics prior to being acquired by J&J for US$1.2 billion. These recent case studies will become invaluable tools in building our pipeline further and winning new business. With this latest round of funding, investment is being made in key growth initiatives across the business as we remain in active discussions with a variety of clients on several further contracts."

Hello Burt

You're actually a shining light o n here given the dross from non holders we've endured

£1mln cap and cashed up now, interesting is the timing as they didn't need to raise as only raised 9mths ago , so I will trust Pete on his word that is was for growth acceleration

Have a look

ONC looks interesting....fallen alot last 4 weeks could be bottomed ?

From debt conversion nearing closure ?

N addition to the Directors' review of monthly management accounts, the Directors have considered the output from both going concern scenarios against the covenants agreed with IPF. These are a minimum cash covenant and a minimum last-twelve-months (LTM) revenue covenant. The former changes by month based on the cash profile discussed with IPF at the time of the October 2024 debt restructuring, and the threshold of the latter is set at 80% of the actual and forecast revenues over the preceding 12-month period. The LTM revenue covenant is designed to track the growth projection of the Company's revenues, and if the 80% threshold is not met, the LTM Revenue covenant ceases to be measured and the cash covenant doubles. Both covenants were met in the first three months of testing, i.e. October, November and December 2024.

The Directors have determined that, based on the base case forecast, the 80% threshold of the LTM revenue covenant will not be met and therefore the doubled level of the cash covenant will apply. Even though revenues continue to increase, they are not doing so at the pace required to meet the increased cash covenants. In this scenario, the Group will require further funding during the year. The Company is most likely to obtain these via financing process(es) involving current and/or new investors and/or a strategic collaboration. If any financing is sufficient to maintain liquidity but not to satisfy the cash covenants, temporary waivers would be sought with IPF (who, since the debt-for-equity transaction, are the largest shareholder), thereby giving the Group further runway to conclude strategic collaborations.

The plausible downside scenario would necessitate further increased inflows of funds and/or renegotiation with IPF.

Based on the above, the Directors have a reasonable expectation that the Group can continue to operate for the foreseeable future, however, there are material uncertainties relating to the quantum and timing of new order intake, the outcome of any financing processes and the outcome of any further renegotiation with IPF. For these reasons, the Directors acknowledge the existence of a material uncertainty which may cast significant doubt over the Group's and the Company's ability to continue in operation.

Still silence from the company

Accepted point Kat

Agree..it's unknown

True to his word (from Burt777) still holds the newly calculated 14mln

4%+ of the newly enlarged capital

Mr Mancrief's has sold his holding at Barclays Investment Solutions Limited and his remaining shareholding of 14,234,711 shares is held in a nominee account at AJ Bell plc holding

 

Following admission of the Placing Shares and the WRAP Retail Offer Shares on 18 February 2025, Mr Mancrief's holding represents 4.6947% of the Company's issued share capital.

Https://www.zoodigital.com/investors/shareholder-information/#investor-content

Now 20% up on my buys

Looking at ZOO also

12th Nov

Not ruling it out but they've stated this in Nov 2024

Ongoing restructuring of cost base to give reduced unit cost of production in H2 FY25 provides strong platform to return to cash breakeven

· Board believes its cash and debt facilities provide the Company with sufficient working capital to meet its operating requirements for the foreseeable future